Samer Ezziddin

7.3k total citations
182 papers, 4.0k citations indexed

About

Samer Ezziddin is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Samer Ezziddin has authored 182 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Radiology, Nuclear Medicine and Imaging, 91 papers in Pulmonary and Respiratory Medicine and 71 papers in Oncology. Recurrent topics in Samer Ezziddin's work include Radiopharmaceutical Chemistry and Applications (86 papers), Prostate Cancer Treatment and Research (58 papers) and Neuroendocrine Tumor Research Advances (40 papers). Samer Ezziddin is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (86 papers), Prostate Cancer Treatment and Research (58 papers) and Neuroendocrine Tumor Research Advances (40 papers). Samer Ezziddin collaborates with scholars based in Germany, United States and Switzerland. Samer Ezziddin's co-authors include Hans‐Jürgen Biersack, Hojjat Ahmadzadehfar, Amir Sabet, Florian Rosar, Fadi Khreish, Stefan Guhlke, Mark Bartholomä, Stephan Maus, Torjan Haslerud and Winfried A. Willinek and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Samer Ezziddin

168 papers receiving 3.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Samer Ezziddin 1.9k 1.8k 1.6k 1.4k 1.1k 182 4.0k
Alexander Haug 2.0k 1.1× 1.8k 1.0× 1.6k 1.0× 1.4k 1.0× 1.0k 1.0× 187 4.9k
Hojjat Ahmadzadehfar 3.2k 1.7× 2.4k 1.4× 1.7k 1.1× 2.7k 1.9× 1.1k 1.0× 201 5.5k
Mark Konijnenberg 3.8k 2.0× 1.8k 1.0× 1.8k 1.2× 1.5k 1.1× 886 0.8× 139 5.4k
Ghassan El‐Haddad 1.5k 0.8× 1.1k 0.6× 625 0.4× 1.7k 1.2× 373 0.3× 97 3.3k
Peter Bernhardt 2.3k 1.2× 1.2k 0.6× 1.3k 0.9× 931 0.7× 688 0.6× 130 3.8k
Mahila Ferrari 1.8k 0.9× 1.2k 0.7× 1.2k 0.8× 663 0.5× 703 0.7× 87 3.1k
Harun Ilhan 1.4k 0.8× 740 0.4× 628 0.4× 1.2k 0.9× 383 0.4× 124 2.5k
Stanislas Pauwels 1.3k 0.7× 1.8k 1.0× 2.1k 1.3× 427 0.3× 1.2k 1.2× 76 3.5k
Jin Chul Paeng 2.2k 1.2× 748 0.4× 428 0.3× 1.3k 0.9× 403 0.4× 218 4.5k
Juri Ruf 1.5k 0.8× 878 0.5× 462 0.3× 1.3k 0.9× 364 0.3× 112 2.9k

Countries citing papers authored by Samer Ezziddin

Since Specialization
Citations

This map shows the geographic impact of Samer Ezziddin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samer Ezziddin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samer Ezziddin more than expected).

Fields of papers citing papers by Samer Ezziddin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samer Ezziddin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samer Ezziddin. The network helps show where Samer Ezziddin may publish in the future.

Co-authorship network of co-authors of Samer Ezziddin

This figure shows the co-authorship network connecting the top 25 collaborators of Samer Ezziddin. A scholar is included among the top collaborators of Samer Ezziddin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samer Ezziddin. Samer Ezziddin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burgard, Caroline, Florian Rosar, Samer Ezziddin, et al.. (2025). [68Ga]Ga-FAPI-04 PET/CT in a patient with endometriosis: a potential game changer?. European Journal of Nuclear Medicine and Molecular Imaging. 52(12). 4350–4351.
2.
3.
Schaefer-Schuler, Andrea, Caroline Burgard, Stephan Maus, et al.. (2024). [161Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC: preliminary dosimetry results and intra-individual head-to-head comparison to [177Lu]Lu-PSMA-617. Theranostics. 14(5). 1829–1840. 22 indexed citations
4.
Rosar, Florian, Caroline Burgard, Mark Bartholomä, et al.. (2024). 225Ac-PSMA-617 Augmentation in High-Risk mCRPC Undergoing 177Lu-PSMA-617 Radioligand Therapy. Clinical Nuclear Medicine. 49(7). 621–629. 5 indexed citations
5.
6.
Rosar, Florian, Fadi Khreish, Caroline Burgard, et al.. (2024). 225Ac-PSMA-617 Augmentation After Insufficient Response Under 177Lu-PSMA-617 Radioligand Therapy in mCRPC: Evaluation of Outcome and Safety From a Prospective Registry (REALITY Study). Clinical Nuclear Medicine. 50(4). e202–e206. 3 indexed citations
7.
Rosar, Florian, Caroline Burgard, Johannes Linxweiler, Mathias Wagner, & Samer Ezziddin. (2023). Histologically Confirmed Testicular Metastasis Revealed by [89Zr]Zr-PSMA-617 PET/CT in a Patient with Biochemical Recurrence of Prostate Cancer and Negative Conventional PSMA PET/CT Imaging. Diagnostics. 13(7). 1352–1352. 2 indexed citations
8.
Rosar, Florian, Fadi Khreish, Robert J. Marlowe, et al.. (2023). Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 50(9). 2899–2909. 13 indexed citations
9.
Burgard, Caroline, Tobias Stemler, Stephan Maus, et al.. (2023). Radiometal Complexes as Pharmacokinetic Modifiers: A Potent 68Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonist Based on the Macrocyclic Metal Chelator NODIA-Me. Molecular Pharmaceutics. 20(12). 6463–6473. 1 indexed citations
10.
Maus, Stephan, Florian Rosar, Juri Ruf, et al.. (2021). Identification, Characterization, and Suppression of Side Products Formed during the Synthesis of [177Lu]Lu-PSMA-617. Journal of Medicinal Chemistry. 64(8). 4960–4971. 18 indexed citations
11.
Holland, Jason P., Tilman Läppchen, Harald Scherer, et al.. (2018). Optimized synthesis and indium complex formation with the bifunctional chelator NODIA-Me. Organic & Biomolecular Chemistry. 16(40). 7503–7512. 15 indexed citations
12.
Ezziddin, Samer, Matthias F. Seidel, Dagmar Wilsmann‐Theis, et al.. (2015). Einführung einer Asymmetrie-Skala des metabolischen Gelenkbefalls abgeleitet aus der konventionellen Skelettszintigrafie. Nuklearmedizin - NuclearMedicine. 54(4). 183–189. 1 indexed citations
13.
Strauß, Andreas C., Georg Goldmann, Samer Ezziddin, et al.. (2014). Klinische Ergebnisse unterschiedlicher Behandlungsoptionen der hämophilen Arthropathie des Ellenbogengelenks nach fehlgeschlagener konservativer Therapie. Hämostaseologie. 34. 3 indexed citations
14.
Ahmadzadehfar, Hojjat, Samer Ezziddin, Kai Wilhelm, et al.. (2014). Überlebenszeit nach Iod-131-markierter Lipiodol-Therapie des hepatozellulären Karzinoms. Nuklearmedizin - NuclearMedicine. 53(2). 46–53. 3 indexed citations
15.
Sabet, Amir, Charlotte J. Yong‐Hing, Torjan Haslerud, et al.. (2014). Kann die Peptid-Radiorezeptortherapie bei diffuser Knochenmetastasierung noch sicher angewendet werden?. Nuklearmedizin - NuclearMedicine. 53(2). 54–59. 11 indexed citations
16.
Sabet, Amir, Hojjat Ahmadzadehfar, Carsten H. Meyer, et al.. (2014). Radioembolisation des hepatozellulären Karzinoms mit 90Y-Mikrosphären. Nuklearmedizin - NuclearMedicine. 53(2). 39–45. 17 indexed citations
17.
Ezziddin, Samer, K. Reichmann, Charlotte J. Yong‐Hing, et al.. (2013). Frühe Prädiktion des Ansprechens auf PRRT. Nuklearmedizin - NuclearMedicine. 52(5). 170–177. 8 indexed citations
18.
Sabet, Amir, et al.. (2012). Detection of chordoma recurrence by F-18 FDG-PET/CT. Iranian Journal of radiation research. 10(2). 109–110. 1 indexed citations
19.
Sabet, Amir, et al.. (2012). Detektion von Knochenmetastasen in Patienten mit gastroenteropankreatischen neuroendokrinen Tumoren – Vergleich von Knochenszintigraphie und 177Lu-Octreotate-Scan. Nuklearmedizin - NuclearMedicine. 51(3). 95–100. 4 indexed citations
20.
Palmedo, H., Peter Albers, Ingo G.H. Schmidt‐Wolf, et al.. (2003). Repeated Bone-Targeted Therapy for Hormone-Refractory Prostate Carcinoma: Randomized Phase II Trial With the New, High-Energy Radiopharmaceutical Rhenium-188 Hydroxyethylidenediphosphonate. Journal of Clinical Oncology. 21(15). 2869–2875. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander Haug Breakdown of academic impact, for papers by Hojjat Ahmadzadehfar Breakdown of academic impact, for papers by Mark Konijnenberg Breakdown of academic impact, for papers by Ghassan El‐Haddad Breakdown of academic impact, for papers by Peter Bernhardt Breakdown of academic impact, for papers by Mahila Ferrari Breakdown of academic impact, for papers by Harun Ilhan Breakdown of academic impact, for papers by Stanislas Pauwels Breakdown of academic impact, for papers by Jin Chul Paeng Breakdown of academic impact, for papers by Juri Ruf
Rankless by CCL
2026